Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.
Clinical trial NCT07679412 · RECRUITING
Trial details
- NCT number
- NCT07679412
- Sponsor
- LucasBio
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-27
- Primary completion
- 2027-08-14
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.